These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11217325

  • 1. Kinetic analysis of the inhibition of matrix metalloproteinases by tissue inhibitor of metalloproteinases (TIMP).
    Hutton M, Willenbrock F.
    Methods Mol Biol; 2001; 151():519-32. PubMed ID: 11217325
    [No Abstract] [Full Text] [Related]

  • 2. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L, Tanaka M, Wait R, Shi YE, Brew K, Nagase H.
    Biochemistry; 2002 Dec 17; 41(50):15025-35. PubMed ID: 12475252
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
    Batra J, Soares AS, Mehner C, Radisky ES.
    PLoS One; 2013 Dec 17; 8(9):e75836. PubMed ID: 24073280
    [Abstract] [Full Text] [Related]

  • 4. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinases.
    Birkedal-Hansen H, Yamada S, Windsor J, Poulsen AH, Lyons G, Stetler-Stevenson W, Birkedal-Hansen B.
    Curr Protoc Cell Biol; 2003 Feb 01; Chapter 10():Unit 10.8. PubMed ID: 18228416
    [Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary.
    Robinson LL, Sznajder NA, Riley SC, Anderson RA.
    Mol Hum Reprod; 2001 Jul 01; 7(7):641-8. PubMed ID: 11420387
    [Abstract] [Full Text] [Related]

  • 7. Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain.
    Kai HS, Butler GS, Morrison CJ, King AE, Pelman GR, Overall CM.
    J Biol Chem; 2002 Dec 13; 277(50):48696-707. PubMed ID: 12374789
    [Abstract] [Full Text] [Related]

  • 8. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
    Li H, Simon H, Bocan TM, Peterson JT.
    Cardiovasc Res; 2000 May 13; 46(2):298-306. PubMed ID: 10773234
    [Abstract] [Full Text] [Related]

  • 9. Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.
    Zhao YG, Xiao AZ, Park HI, Newcomer RG, Yan M, Man YG, Heffelfinger SC, Sang QX.
    Cancer Res; 2004 Jan 15; 64(2):590-8. PubMed ID: 14744773
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long-term marrow cultures.
    Marquez-Curtis LA, Dobrowsky A, Montaño J, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A.
    Br J Haematol; 2001 Dec 15; 115(3):595-604. PubMed ID: 11736941
    [Abstract] [Full Text] [Related]

  • 11. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
    Hoheisel G, Sack U, Hui DS, Lai F, Chan KS, Choi CH, Schauer J, Tannapfel A.
    Pneumologie; 2004 May 15; 58(5):305-8. PubMed ID: 15162254
    [Abstract] [Full Text] [Related]

  • 12. MMP-TIMP interaction depends on residue 2 in TIMP-4.
    Stratmann B, Farr M, Tschesche H.
    FEBS Lett; 2001 Nov 02; 507(3):285-7. PubMed ID: 11696356
    [Abstract] [Full Text] [Related]

  • 13. Challenges in Matrix Metalloproteinases Inhibition.
    Laronha H, Carpinteiro I, Portugal J, Azul A, Polido M, Petrova KT, Salema-Oom M, Caldeira J.
    Biomolecules; 2020 May 05; 10(5):. PubMed ID: 32380782
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.
    Exp Eye Res; 2002 May 05; 74(5):577-84. PubMed ID: 12076079
    [Abstract] [Full Text] [Related]

  • 15. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.
    Lein M, Jung K, Laube C, Hübner T, Winkelmann B, Stephan C, Hauptmann S, Rudolph B, Schnorr D, Loening SA.
    Int J Cancer; 2000 Mar 15; 85(6):801-4. PubMed ID: 10709099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K, Bode W.
    Mol Biotechnol; 2003 Nov 15; 25(3):241-66. PubMed ID: 14668538
    [Abstract] [Full Text] [Related]

  • 18. Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer Effects.
    Duan JX, Rapti M, Tsigkou A, Lee MH.
    PLoS One; 2015 Nov 15; 10(8):e0136384. PubMed ID: 26308720
    [Abstract] [Full Text] [Related]

  • 19. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 20. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O, Ganster M, Baumgartner I, Nieselt K, Djonov V.
    J Vasc Res; 2007 Jun 15; 44(3):202-13. PubMed ID: 17337906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.